Clinical Trial Update: Weight Loss Study: Genetics and Response to Naltrexone/Bupropion [Phase 4]

View source ↗

Summary

A Phase 4 trial at Columbia University is recruiting to study genetic factors that influence response to the weight-loss drug combination naltrexone/bupropion i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• CONTRAVE (bupropion/naltrexone)

Snippet

Sponsor: Columbia University | Conditions: Obesity | Phase 4 | Status: RECRUITING